| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO
1 company
Kintz Samuel is a President And CEO at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $40.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sell | 12,000 | $21.66 | $259,901.54 | -0.6% | +9.8% | +0.1% | |
| May 28, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $23.18 | $278,210.05 | -68.9% | -1.2% | -30.8% | |
| Apr 25, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $16.89 | $202,700.40 | -100% | +43.1% | +8.5% | |
| Apr 11, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 47,709 | $25.04 | $1,194,700.15 | -100% | -3.2% | -30.7% | |
| Mar 25, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $17.56 | $210,661.12 | -72.0% | +22.8% | +19.9% | |
| Feb 26, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $16.89 | $202,653.44 | -73.3% | +32.2% | +14.6% | |
| Jan 25, 2024 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $15.69 | $188,229.50 | -55.9% | +7.0% | +33.8% | |
| Dec 26, 2023 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $14.64 | $175,708.80 | -100% | +22.7% | +56.7% | |
| Dec 22, 2023 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 8,195 | $13.05 | $106,915.14 | -100% | +21.6% | +51.3% | |
| Dec 20, 2023 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 7,779 | $13.01 | $101,238.24 | -100% | +43.9% | +87.6% |